Blog – Page 22 – Katalyst Wealth

Glenmark Lifesciences – Special situation opportunity

October 13, 2023

Dear Members, We have released 13th Oct’23: Special situation opportunity on the proposed open offer and promoter change in Glenmark Lifesciences. The same has also been produced below. For details and other updates, please log into the website at the following link – http://katalystwealth.com/index.php/my-account/ Note: For any queries, mail us at [email protected] Date: 13th Oct’23 CMP – 650.00 (BSE); 650.25 (NSE) Rating – Positive – 4% weightage; this is not an investment advice (refer rating interpretation at the end) …

[Special Situation] – Shreyas Shipping & Logistics…delisting case

October 6, 2023

Hello Sir, Hope you are doing well. On 23rd May’23, we released Shreyas Shipping & Logistics (NSE Code – SHREYAS) Special situation opportunity for our Alpha + members and would like to share with you details on the same. While the special situation corporate action is still ongoing, we closed it for our members around 380 odd levels. Basically, we initiated it in May’23 around 331 odd levels. Post that the company announced the floor price for delisting as Rs 292/- and then shared an…

[Stock notes] – Goldiam International…strong demand for Lab Grown Diamonds

October 6, 2023

Hello Sir, Hope you are doing well. Recently I was reading about Lab Grown Diamonds (LGD) which are fast gaining acceptability in the Indian market. As per our understanding, currently Goldiam International is the only major listed company dealing in LGDs. LGDs are chemically, optically and physically identical to earth mined diamonds, but are significantly more affordable. As per Economic Times article, a carat of LGD costs ₹60,000-70,000, a fraction of ₹10-11 lakh for a natural diamond. Further, 60% YOY growth in the demand…

[New Stock Report]: Management targeting 600 cr + sales in FY 26 with EBITDA 20-22%

October 6, 2023

Hello Sir, Hope you are doing well. On 29th Sep’23, Friday evening, we released our new stock recommendation for our Alpha and Alpha + Members. The management has introduced a new product line wherein they are targeting 600 crore + sales in FY 26 with EBITDA margins of 20-22% If the management is able to achieve the above numbers, the company will mostly likely double its profit over the next 3-4 years. Here are some other interesting details about the company: 30…